Cite
Targeting Tumor Angiogenesis in Combination with Endocrine Therapy in Patients with Hormone-Receptor Positive Metastatic Breast Cancer.
MLA
Jhaveri, Komal, et al. “Targeting Tumor Angiogenesis in Combination with Endocrine Therapy in Patients with Hormone-Receptor Positive Metastatic Breast Cancer.” European Journal of Clinical & Medical Oncology, vol. 3, no. 4, Oct. 2011, pp. 24–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=69755162&authtype=sso&custid=ns315887.
APA
Jhaveri, K., Traina, T., Rugo, H., Geneus, S., Patil, S., Hudis, C., & Dickler, M. N. (2011). Targeting Tumor Angiogenesis in Combination with Endocrine Therapy in Patients with Hormone-Receptor Positive Metastatic Breast Cancer. European Journal of Clinical & Medical Oncology, 3(4), 24–32.
Chicago
Jhaveri, Komal, Tiffany Traina, Hope Rugo, Stephanie Geneus, Sujata Patil, Clifford Hudis, and Maura N. Dickler. 2011. “Targeting Tumor Angiogenesis in Combination with Endocrine Therapy in Patients with Hormone-Receptor Positive Metastatic Breast Cancer.” European Journal of Clinical & Medical Oncology 3 (4): 24–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=69755162&authtype=sso&custid=ns315887.